InSeCur: Interplay of Self-Criticism and Symptom Severity Over the Course of In-patient Psychotherapeutic Treatment
Study Details
Study Description
Brief Summary
The purpose of this study is to assess the interplay between self-criticism and symptom severity in patients undergoing psychotherapeutic treatment.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Participants are recruited at the University Clinic Heidelberg at the beginning of their (usually) 8-week in-patient treatment, consisting of somatic and psychotherapeutic aspects. After informed consent, patients routinely fill out weekly questionnaires about their self-criticism and their symptom severity. The overall aim of this study is to disentangle stable (between-person) effects of both self-criticism and symptom severity from within-person effects happening over time in order to better understand what drives what, or in other words, their dynamic interplay. The analysis is based on the weekly assessment of the patients. All patients receive the standard care of the in-patient treatment.
Study Design
Outcome Measures
Primary Outcome Measures
- SCL-K11 [Weekly Assessments over the course of the in-patient treatment (usually about 8 weeks)]
Symptom Check-List German Short Version with 11 Items
- TDEQ-12 (Subscale Self-Criticism [Weekly Assessments over the course of the in-patient treatment (usually about 8 weeks)]
Theoretical Depressive Experiences Questionnaire German Short Version with 12 Items: Subscale Self-Criticism
Eligibility Criteria
Criteria
Inclusion Criteria:
- Undergoing in-patient treatment at the University Clinic Heidelberg (Klinik für Allgemeine Innere Medizin und Psychosomatik)
Exclusion Criteria:
- none
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University Hospital Heidelberg
Investigators
- Study Chair: Ulrike Dinger, Prof, University Hospital Heidelberg
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ST-TDEQSCL-2021